Giants looking to trade Kevin Frandsen

0 Comments

Henry Schulman of the San Francisco Chronicle reports that “the Giants have made it known widely throughout baseball that they are willing to trade infielder Kevin Frandsen.”
According to Schulman the Giants recently showcased Frandsen at shortstop for any interested teams because Matt Downs has passed him on their infield depth chart, but few people seem to think the 28-year-old can still handle the position defensively after a torn Achilles’ tendon caused him to miss all of 2008.
He had a solid bounce-back season at Triple-A, batting .295/.352/.438 with 13 homers in 110 games, but went just 7-for-50 (.140) with the Giants and is a career .240/.304/.341 hitter in 453 plate appearances as a big leaguer. Frandsen’s track record suggests he’s better than that, but his bat is likely at most a tick above utility man-caliber and as strictly a second baseman his glove may not even be that good.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.